This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 14:37, 19 September 2011 (Updating {{drugbox}} (changes to watched fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:37, 19 September 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (changes to watched fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Trimethoprim/polymyxin B" – news · newspapers · books · scholar · JSTOR (February 2011) (Learn how and when to remove this message) |
Combination of | |
---|---|
Trimethoprim | Nucleic acid inhibitor antibiotic |
Polymyxin | Cell envelope antibiotic |
Clinical data | |
Routes of administration | Eye drops |
ATC code | |
Identifiers | |
PubChem CID | |
CompTox Dashboard (EPA) | |
(verify) |
The drug combination trimethoprim/polymyxin (INNs, trade name Polytrim) is an antimicrobial solution for topical ophthalmic use in the treatment of acute bacterial conjunctivitis and blepharoconjunctivitis.
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |